FourThought Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

FourThought Financial’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$35K	Hold	507	–	–	0.01%	721
2022 Q2	$34K	Buy	507 +41	+9%	+$2.61K	0.01%	730
2022 Q1	$38K	Buy	466 +90	+24%	+$9.2K	﹤0.01%	746
2021 Q4	$55K	Hold	376	–	–	0.01%	637
2021 Q3	$66K	Hold	376	–	–	0.01%	611
2021 Q2	$60K	Buy	376 +180	+92%	+$28.9K	0.01%	648
2021 Q1	$33K	Buy	+196	New	+$38.8K	﹤0.01%	794

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FourThought Financial's MRTX Position: Q3 2022 in Review

FourThought Financial held its Mirati Therapeutics, Inc. Common Stock (MRTX) position steady in Q3 2022 at 507 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #721.

FourThought Financial first reported a position in MRTX in Q1 2021 and has held it in 7 quarters since. The position peaked at $66K in Q3 2021. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

FourThought Financial held 507 shares of Mirati Therapeutics, Inc. Common Stock worth $35K as of Q3 2022.
FourThought Financial left its Mirati Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
Mirati Therapeutics, Inc. Common Stock made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #721 holding.
FourThought Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 7 quarters since.
FourThought Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $66K in Q3 2021.
243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.